KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Hologic (HOLX) Long-Term Investments (2024 - 2025)

Hologic (HOLX) has disclosed Long-Term Investments for 2 consecutive years, with $196.7 million as the latest value for Q4 2025.

Quarterly Long-Term Investments rose 310.65% to $196.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $196.7 million through Dec 2025, up 310.65% year-over-year, with the annual reading at $243.2 million for FY2025, 152.28% up from the prior year.
Long-Term Investments hit $196.7 million in Q4 2025 for Hologic, down from $243.2 million in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $243.2 million in Q3 2025 to a low of $47.9 million in Q4 2024.